Results 41 to 50 of about 21,302 (228)

Edoxaban, a Factor Xa-Specific Direct Oral Anticoagulant, Significantly Suppresses Tumor Growth in Colorectal Cancer Colon26-Inoculated BALB/c Mice

TH Open, 2023
Introduction Certain low-molecular-weight heparins have been reported to reduce tumor growth and metastasis in tumor cell-inoculated mouse models and cancer patients.
Keiichi Hiramoto, Nobuyuki Akita, Junji Nishioka, Koji Suzuki   +3 more
doaj   +1 more source

Management of DOAC in patients undergoing planned surgery or invasive procedure: FCSA position paper

Thrombosis and Haemostasis, 2021
Patients on anticoagulant treatment are constantly increasing, with an estimated prevalence in Italy of 2% of the total population. About a quarter of the anticoagulated patients require temporary cessation of direct oral anticoagulants (DOACs) or ...
A. Squizzato, D. Poli, D. Barcellona, A. Ciampa, E. Grandone, C. Manotti, M. Moia, V. Toschi, A. Tosetto, S. Testa   +9 more
semanticscholar   +1 more source

The use of direct acting oral anticoagulants in patients with COVID-19 infection

Journal of Community Hospital Internal Medicine Perspectives, 2021
The use of direct-acting oral anticoagulants (DOACs) has increased rapidly in the last decade; becoming the mainstay for both the prophylaxis and the treatment of venous thromboembolism in various situations including non-valvular atrial fibrillation ...
Ragia Aly, Sachin Gupta, Balraj Singh, Parminder Kaur, Kunhwa Kim, Sorab Gupta   +5 more
doaj   +1 more source

Development and validation of an analytical method for the determination of direct oral anticoagulants (DOAC) and the direct thrombin-inhibitor argatroban by HPLC–MS/MS

Journal of Thrombosis and Thrombolysis, 2021
Since direct oral anticoagulants (DOAC) are administered frequently to an elderly, co-morbid population, medical emergencies including trauma, acute bleeding or organ failure are not uncommon.
Lea Brückner, J. Beyer-Westendorf, O. Tiebel, J. Pietsch   +3 more
semanticscholar   +1 more source

The effect of chronic DOAC treatment on clinical outcomes of hospitalized patients with COVID‐19

International journal of clinical practice, 2021
Recent findings indicate that thrombosis is one of the underlying pathophysiology and complication of COVID‐19 infection. Therefore, the prognosis of the disease may be more favourable in people who were under oral anticoagulant treatment before the ...
B. Aslan, Abdurrahman Akyüz, F. Işık, M. Çap, Ü. İnci, İlyas Kaya, M. Karahan, A. Aktan, Ö. Bilge, M. Özbek, B. Altıntaş, B. Boyraz   +11 more
semanticscholar   +1 more source

The effect of DOAC‐Stop® on several oral and parenteral anticoagulants

International Journal of Laboratory Hematology, 2021
Dear Editors, DOACStop® is a hydrophobic binding agent, containing activated charcoal, which can absorb the direct oral anticoagulants (DOACs) from plasma samples in vitro.1 It neutralized the effect of apixaban, edoxaban, rivaroxaban and dabigatran on ...
Nicoletta Riva, K. Vella, K. Hickey, Peter Gatt, Charlie Grima, D. Zammit, W. Ageno, S. Kitchen, M. Makris, A. Gatt   +9 more
semanticscholar   +1 more source

Suspected Rivaroxaban-Induced Anaphylaxis Secondary to Ingestion of Rivaroxaban and Nimesulide Without Cross-Reactivity to Dabigatran – A Case Report

Journal of Asthma and Allergy, 2023
Gediminas Gumbis,1 Inga Česnavičiūtė,1 Gabija Didžiokaitė,1,2 Daiva Gegeckienė,3 Violeta Kvedarienė4,5 1Faculty of Medicine, Vilnius University, Vilnius, Lithuania; 2Institute of Clinical Medicine, Faculty ...
Gumbis G, Česnavičiūtė I, Didžiokaitė G, Gegeckienė D, Kvedarienė V   +4 more
doaj  

Inhospital outcomes of myocardial infarction in patients receiving direct oral anticoagulants

Рациональная фармакотерапия в кардиологии, 2023
Aim. To evaluate the clinical course and inhospital outcomes of myocardial infarction (MI) in patients receiving continuous direct oral anticoagulant (DOAC) therapy.Material and methods. Data from 390 patients treated for MI were included in the analysis.
M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina   +2 more
doaj   +1 more source

Performance Characteristics of DOAC Dipstick in Determining Direct Oral Anticoagulants in Urine

Clinical and applied thrombosis/hemostasis, 2021
Testing for direct oral anticoagulants (DOACs) in patient urine may facilitate medical treatment decisions. The aim of this study was to investigate interobserver variability by 2 independent observers compared to laboratory staff in the visual ...
J. Harenberg, Andrea Martini, S. Du, S. Krämer, C. Weiss, S. Hetjens   +5 more
semanticscholar   +1 more source

Evaluation of the Hemocompatibility of the Direct Oral Anticoagulant Apixaban in Left Ventricular Assist Devices: The DOAC LVAD Study.

JACC. Heart failure
BACKGROUND Patients receiving left ventricular assist device (LVAD) support require long-term anticoagulation to reduce the risk of thromboembolic complications.
Palak Shah, M. Looby, Matthew Dimond, P. Bagchi, Bhruga Shah, I. Isseh, Allman T Rollins, Ahmad A. Abdul-Aziz, Jamie Kennedy, Daniel Tang, Katherine M. Klein, Samantha Casselman, Christen Vermeulen, Wendy Sheaffer, Meredith Snipes, S. Sinha, Christopher M. O’Connor   +16 more
semanticscholar   +1 more source